Marina Ferrarini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies.

Journal: Nature communications

Published: March 06, 2024

In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo.

In vitro models of the crosstalk between multiple myeloma and stromal cells recapitulate the mild NF-κB activation observed in vivo.

Journal: Cell death & disease

Published: October 10, 2023

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.

Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.

Journal: Rheumatology (Oxford, England)

Published: September 15, 2022

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.

Journal: STAR protocols

Published: August 22, 2022

3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations.

3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations.

Journal: Antibodies (Basel, Switzerland)

Published: June 01, 2022

Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis.

Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS-mutated histiocytosis.

Journal: Rheumatology (Oxford, England)

Published: September 15, 2021

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease.

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease.

Journal: Blood

Published: October 20, 2020

A Novel Histiocytosis With Synovial and Skin Involvement.

A Novel Histiocytosis With Synovial and Skin Involvement.

Journal: Annals of internal medicine

Published: September 07, 2020

miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.

miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.

Journal: Cell communication and signaling : CCS

Published: February 25, 2020

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.

ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies.

Journal: Haematologica

Published: November 14, 2019

Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer.

Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer.

Journal: Journal of leukocyte biology

Published: August 29, 2019

3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target.

3D culture of Erdheim-Chester disease tissues unveils histiocyte metabolism as a new therapeutic target.

Journal: Annals of the rheumatic diseases

Published: September 12, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026